Clinitech Laboratory IPO details Today : Clinitech Laboratory IPO details Today is Open on 25 July 2024 and Close on 29 July 2024. Clinitech Laboratory IPO to Raise 602,400 shares (Approx ₹5.78 Cr) via IPO. The Fresh issue of 602,400 shares (Approx ₹5.78 Cr).
Clinitech Laboratory was incorporated in 1990 We are a provider of diagnostic and healthcare Tests and services through chain of 8 diagnostic centers in and around Thane and Navi Mumbai. Our Promoters have 30+ years of experience in diagnostic business.
We conduct more than 3 Lakh tests per year in our NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited labs equipped with modern technology and high-end equipment. We conduct more than 150 tests at our centres which are classified under various heads as under.
- Biochemistry tests
- Immunology tests
- Hematology tests
- Molecular Biology tests
- Serology tests
- Microbiology tests
- Histopathology tests
OUR STRATEGIES
- Leveraging our existing products / services portfolio
- Leveraging our Infrastructure
- Collaboration and continuous Training
- Inorganic Growth
Our Products and Services
Clinical pathology is a medical specialty that focuses on the diagnosis of diseases and conditions through the analysis of bodily fluids and tissues. It includes various laboratory tests and techniques such as blood tests, urine analysis, and tissue biopsies to help healthcare professionals understand the underlying causes of a patient’s symptoms and guide treatment
decisions. Clinical pathologists play a crucial role in interpreting test results and providing valuable information to aid in patient care. Brief description of various tests conducted at our diagnostic centres:
- Biochemistry plays a crucial role in pathology, the study of disease processes. It helps us understand the molecular and biochemical mechanisms underlying diseases.
- A serology test is a blood test that analyzes serum, which is the clear liquid portion of blood. This test is often used to detect antibodies in the blood, which are produced by the immune system in response to infections or other foreign substances. Serology tests can be used to diagnose various infectious diseases, including viral infections like HIV, Hepatitis, and COVID-19.
- Microbiology tests in pathology involve the study of microorganisms such as bacteria, viruses, fungi, and parasites to diagnose infectious diseases and understand their characteristics. These tests are crucial for identifying the causative agents of infections, determining their susceptibility to antibiotics, and monitoring treatment efficacy. Test like (Bacterial Culture, Viral Culture, Tuberculosis (TB), Molecular Tests etc.) is done under microbiology.
- Hematology tests in pathology are diagnostic procedures that involve the examination of blood samples to assess various aspects of blood and blood-related disorders. These tests are crucial for diagnosing and monitoring conditions such as anemia, leukemia, clotting disorders.
Clinitech Laboratory IPO Date & Price Band Details
| IPO Open Date | 25 July 2024 |
|---|---|
| IPO Close Date | 29 July 2024 |
| IPO Size | 602,400 shares (Approx ₹5.78 Cr) |
| Fresh Issue | 602,400 shares (Approx ₹5.78 Cr) |
| Lot Size | 1200 Shares |
| IPO Face Value | ₹10 Per Equity Share" |
| IPO Price Band | ₹96 Per Every Share |
| IPO Listing On | BSE SME |
| IPO Retail Quota | 50% |
| IPO QIB Quota | -% |
| IPO NII Quota | 50% |
| DRHP Draft | Click Here |
| Anchor Investor | Click Here |
Clinitech Laboratory IPO Market Lot Details
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 1200 | ₹115,200 |
| Retail Maximum | 1 | 1200 | ₹115,200 |
| S-HNI Minimum | 2 | 2400 | ₹230,400 |
Object of the Issue
- Expansion of Diagnostic Centres.
- General Corporate Purposes.
Clinitech Laboratory IPO Allotment & Listings (Details)
| IPO Open Date | 25 July 2024 |
|---|---|
| IPO Close Date | 29 July 2024 |
| Basis of Allotment | 30 July 2024 |
| Refunds | 31 July 2024 |
| Credit to Demat Account | 31 July 2024 |
| IPO Listing Date | 1 August 2024 |
Clinitech Laboratory Financial Reports
| ₹ in Crores | |||
|---|---|---|---|
| Year | Revenue | Expense | PAT |
| 2024 | ₹6.44 | ₹5.42 | ₹0.37 |
| 2023 | ₹6.36 | ₹5.00 | ₹0.61 |
| 2022 | ₹6.46 | ₹5.32 | ₹0.51 |
Our Company Promoters
- Jagdish Umakant Nayak
- Jyoti Jagdish Nayak
Qualitative Factors
- NABL Accreditation.
- Chain of Diagnostic Centers.
- Experienced Promoter and management team with strong industry expertise and successful track record.
- Strong and long-standing customer relationships.
Clinitech Laboratory IPO Comparison Listed Industry Peers Group
| Company Name | Face Value | EPS | P/E Ratio | Ro NW (%) | NAV Per | Revenue (₹ in Crore) |
|---|---|---|---|---|---|---|
| Clinitech | 10.00 | 4.09 | 23.49 | 27.74% | 15.87 | 6.36 |
| Peer Group | ||||||
| Dr Lalpath Labs | 10.00 | 29.12 | 84.26 | 715.53% | 203.91 | 2058.60 |
| Thyrocare | 10.00 | 12.16 | 55.16 | 12.02% | 101.12 | 635.09 |
| Krsnaa Diagnostics | 5.00 | 19.78 | 35.85 | 8.41% | 235.28 | 506.50 |
Comparison of Accounting Ratios with Listed Peer Group Companies
- Clinitech
- Dr Lalpath Labs
- Thyrocare
- Krsnaa Diagnostics
Also Read: VVIP Infratech IPO details, Date, Price, GMP, Review
Clinitech Laboratory Company Contact Details
AL-1/545, Sector 16, Airoli, Opposite Radhikabai Meghe
Vidyalaya, Navi Mumbai, Thane – 400708,
Maharashtra, India
Tel: +91 22 27792281 / +91 9004072223
E-mail: ipo@clinitechlab.com
Website: www.ctllab.in
Clinitech Laboratory IPO Registrar
BIGSHARE SERVICES PRIVATE LIMITED
S6-2, 6th Floor, Pinnacle Business Park,
Mahakali Caves Road, Next to Ahura Centre,
Andheri East, Mumbai – 400 093, Maharashtra, India
Tel. No.: +91 22 6263 8200
Email: ipo@bigshareonline.com
Website: www.bigshareonline.com
Investor Grievance Email: investor@bigshareonline.com
Contact Person: Babu Rapheal C.
3 thoughts on “Clinitech Laboratory IPO details, Date, Price, GMP, Review”